[HTML][HTML] Minimal residual disease dynamics after venetoclax-obinutuzumab treatment: extended off-treatment follow-up from the randomized CLL14 study

O Al-Sawaf, C Zhang, T Lu, MZ Liao… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
PURPOSE The CLL14 study has established one-year fixed-duration treatment of venetoclax
and obinutuzumab (Ven-Obi) for patients with previously untreated chronic lymphocytic …

The PSMA-targeting half-life extended BiTE therapy AMG 160 has potent antitumor activity in preclinical models of metastatic castration-resistant prostate cancer

…, J Wahl, P Bogner, F Aeffner, M Friedrich, MZ Liao… - Clinical Cancer …, 2021 - AACR
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) remains a disease with
high unmet medical need, as most patients do not achieve durable response with available …

Model‐Informed Therapeutic Dose Optimization Strategies for Antibody–Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration …

MZ Liao, D Lu, M Kågedal, D Miles… - Clinical …, 2021 - Wiley Online Library
Antibody–drug conjugates (ADCs) combine the specificity of an antibody with the cytotoxicity
of a chemical agent. They represent a rapidly evolving area of oncology drug development …

Effects of pregnancy on the pharmacokinetics of metformin

MZ Liao, SKF Nichols, M Ahmed, S Clark… - Drug Metabolism and …, 2020 - ASPET
This study’s primary objective was to fully characterize the pharmacokinetics of metformin in
pregnant women with gestational diabetes mellitus (GDM) versus nonpregnant controls. …

Clinical pharmacology considerations on recombinant adeno‐associated virus–based gene therapy

K Sun, MZ Liao - The Journal of Clinical Pharmacology, 2022 - Wiley Online Library
Recombinant adeno‐associated virus (AAV) is currently the most widely used platform for in
vivo gene therapy. Clinical pharmacology is a central field for AAV gene therapy, …

Simultaneous quantification of 25-hydroxyvitamin D3-3-sulfate and 25-hydroxyvitamin D3-3-glucuronide in human serum and plasma using liquid chromatography …

C Gao, MC Bergagnini-Kolev, MZ Liao, Z Wang… - … of Chromatography B, 2017 - Elsevier
25-hydroxyvitamin D 3 -3-sulfate (25-OHD 3 -S) and 25-hydroxyvitamin D 3 -3-glucuronide (25-OHD
3 -G) are major conjugative metabolites of vitamin D 3 found in the systemic …

P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine

MZ Liao, C Gao, LM Shireman, B Phillips… - Pharmacological …, 2017 - Elsevier
… Multiple reaction monitoring transitions for each analyte and internal standard were m/z 414.2
> 83.1 for NBUP, m/z 590.3 > 414.2 for NBUP-G, and m/z 417.2 > 83.1for NBUP-d3. NBUP-…

Hepatic transport of 25-hydroxyvitamin D3 conjugates: a mechanism of 25-hydroxyvitamin D3 delivery to the intestinal tract

C Gao, MZ Liao, LW Han, KE Thummel… - Drug Metabolism and …, 2018 - ASPET
Vitamin D 3 is an important prohormone critical for maintaining calcium and phosphate
homeostasis in the body and regulating drug-metabolizing enzymes and transporters. 25-…

Buprenorphine, norbuprenorphine, R-methadone, and S-methadone upregulate BCRP/ABCG2 expression by activating aryl hydrocarbon receptor in human placental …

NK Neradugomma, MZ Liao, Q Mao - Molecular pharmacology, 2017 - ASPET
Opioid dependence during pregnancy is a rising concern. Maintaining addicted pregnant
women on long-acting opioid receptor agonist is the most common strategy to manage drug …

Clinical pharmacology perspectives for adoptive cell therapies in oncology

W Huang, J Li, MZ Liao, SN Liu, J Yu… - Clinical …, 2022 - Wiley Online Library
Adoptive cell therapies (ACTs) have shown transformative efficacy in oncology with five US
Food and Drug Administration (FDA) approvals for chimeric antigen receptor (CAR) T‐cell …